Financial Gravity Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26
Closed -$732 1275
2023
Q2
$732 Sell
26
-4
-13% -$105 ﹤0.01% 903
2023
Q1
$2.23K Buy
+30
New +$871 0.07% 289
2022
Q4
Sell
-330
Closed -$1.99K 1413
2022
Q3
$1.99K Buy
+330
New +$8.62K 0.07% 295
2019
Q4
Sell
-306
Closed -$11K 1389
2019
Q3
$11K Sell
306
-391
-56% -$14.9K 0.01% 588
2019
Q2
$30K Buy
697
+668
+2,303% +$28.6K 0.02% 413
2019
Q1
$1K Buy
+29
New +$1.3K ﹤0.01% 1036
2018
Q3
$1K Buy
23
+7
+44% +$450 ﹤0.01% 1075
2018
Q2
$1K Sell
16
-2
-11% -$106 ﹤0.01% 1097
2018
Q1
$1K Buy
+18
New +$855 ﹤0.01% 1066

Other funds holding AVNS

Financial Gravity Asset Management's AVNS Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 26 shares — an estimated $732 sold.

Financial Gravity Asset Management first reported a position in AVNS in Q1 2018 and held it in 9 quarters. The position peaked at $30K in Q2 2019. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Financial Gravity Asset Management reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 26 Avanos Medical shares in Q3 2023, an estimated $732.
  • Financial Gravity Asset Management first reported a position in Avanos Medical in Q1 2018 and held it in 9 quarters.
  • Financial Gravity Asset Management's Avanos Medical position peaked at $30K in Q2 2019.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.